Neratinib

An orally available, 6,7-disubstituted-4-anilinoquinoline-3-carbonitrile irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity. Neratinib binds to the HER-2 receptor irreversibly, thereby reducing autophosphorylation in cells, apparently by targeting a cysteine residue in the ATP-binding pocket of the receptor. Treatment of cells with this agent results in inhibition of downstream signal transduction events and cell cycle regulatory pathways; arrest at the G1-S (Gap 1/DNA synthesis)-phase transition of the cell division cycle; and ultimately decreased cellular proliferation. Neratinib also inhibits the epidermal growth factor receptor (EGFR) kinase and the proliferation of EGFR-dependent cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

NEPSY

A series of neurocognitive tests for children from 3 to 16 years of age. NEPSY can be used for general, diagnostic, selective,…

Neprilysin

Neprilysin (750 aa, ~86 kDa) is encoded by the human MME gene. This protein is involved in the metabolism of biologically active…

Nepidermin

A recombinant form of the naturally-occurring polypeptide human epidermal growth factor with potential epithelial regenerative and cytoprotective activities. Upon topical application, recombinant…

Nephroureterectomy

Surgery to remove a kidney and its ureter. Also called ureteronephrectomy.

Nephrotoxicity Inhibition

Nephrotoxicity Inhibition involves interference with, or restraint of, the activities of an agent, a biologic molecule or complex, or a cell having…

Nephrotoxic

Poisonous or damaging to the kidney.